We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
Could also give 4x 2 weekly dose dense Paclitaxel instead of weekly. Also consider BRCA and risk reduction contralateral if not already done.
BRCA status? I would consider her for a clinical trial with cdKi in the adjuvant setting.
Neoadjuvant cdk4/6 inhibitor plus aromataseinhibitor?
The ovarian ablation, premature menopause may be associated with long-term health effects, including cardiovascular disease, so in this case 10 years of OFS is something to consider, maybe OFS for 5 years and continuing tamoxifen could be a good strategy, bisphosphonates as prevention of bone loss is another good recommendation. I agree with the importance of Brca status in this patient.
What about radiotherapy of the thoracic wall?
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.